Moderna, Merck Drugs Combined Shown Effective Against Melanoma
Voice of America
FILE - People pose with a syringe in front of a Moderna logo. Moderna, along with fellow pharmaceutical company Merck, announced Dec. 14, 2023, they had found success in reducing the chance of recurrence of melanoma by combining a Moderna vaccine with Merck's Keytruda.
U.S. pharmaceutical companies Moderna and Merck say a clinical trial for an experimental Moderna mRNA vaccine used in combination with the Merck cancer therapy drug Keytruda reduced the chance of recurrence or death from melanoma by nearly 50%.
A drone view shows the ancient geoglyph of 'El Gigante de Tarapaca' placed on 'Unita' hill close to 'Huara' town area, in Atacama desert, Iquique, Chile, Oct. 28, 2024. A man walks on ‘Cerro Dragon' nature sanctuary dune while practicing sandboard with Iquique city in the background, at Atacama desert, Iquique, Chile, Oct. 29, 2024.